JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Menon, M. K.
Right arrow Articles by Bapna, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Menon, M. K.
Right arrow Articles by Bapna, J. S.
Journal of Pharmacology And Experimental Therapeutics, Vol. 156, Issue 1, 63-69, 1967
Copyright © 1967 by American Society for Pharmacology and Experimental Therapeutics


MODIFICATION OF THE EFFECTS OF TRANQUILIZERS IN ANIMALS TREATED WITH agr-METHYL-l-TYROSINE

M. K. Menon 1, P. C. Dandiya 1, and J. S. Bapna 1

1 Department of Pharmacology, S.M.S. Medical College, Jaipur, India

Experiments were performed to study the effects of reserpine, chlorpromazine and meprobamate in animals with lowered tissue norepinephrine levels. In rats treated with three doses of agr-methyl-l-tyrosine (AMT, 80 mg/kg) over a period of 24 hr, the brain norepinephrine level was lowered by 65%. In AMT-treated animals the pharmacologic actions of reserpine and chlorpromazine, namely, hypothermia and potentiation of barbiturate hypnosis in mice as well as blockade of conditioned avoidance response of trained rats, were markedly enhanced. Meprobamate was ineffective in causing any significant effect either in control or in AMT-treated animals. The significance of these findings is discussed. Although the role of dopamine depletion cannot be ruled out since dopamine estimations were not made, it seems that the lowering of brain norepinephrine caused by reserpine, though by itself insufficient to produce sedation, contributes to reserpine's tranquilizing effect by lowering the tone of the ergotropic system of the hypothalamus.

Submitted on May 10, 1966
Accepted on September 23, 1966







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics.